3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
1
Neoplasms
1
Nausea
1
Interventions
Dexamethasone
11
Palonosetron
9
casopitant
6
Ondansetron
6
Granisetron
6
Aprepitant
5
netupitant, palosentron drug combination
3
Duration of Therapy
2
netupitant
1
dolasetron
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
alizapride
1
Tropisetron
1
Tablets
1
NDC80 protein, human
1
Metoclopramide
1
Injections, Intravenous
1
Exercise
1
Dronabinol
1
Docetaxel
1
Cyclophosphamide
1
Calcium Dobesilate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Vomiting
×
dolasetron
×
Clear all
NCT01636947
2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4
Completed
494 enrolled
14 charts